Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Market Cap	$2.38B	P/E Ratio	27.88
52W High	$163.35	52W Low	$48.30
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	46.9%	52W Position	4.3%
Overall Score	40	Value Score	65
Quality Score	55	Technical Score	--

EPS Current Est	$1.91	EPS Next Est	$2.51
EPS Growth Est	+31.4%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INSP	$53.25	-2.15%	489.87K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INSP	$53.25	-2.1%	489.87K
3
4
5
6

INSP

INSP

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Inspire Medical Systems Inc. Data in Excel

Get Inspire Medical Systems Inc. Data in Excel